The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Insulin Drug Delivery Devices Market Research Report 2025
Synopsis
Insulin delivery devices that are currently available for the administration of insulin include syringes, insulin infusion pumps, jet injectors and pens.
The global Insulin Drug Delivery Devices market was valued at US$ 13980 million in 2023 and is anticipated to reach US$ 19310 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insulin Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Drug Delivery Devices.
Report Scope
The Insulin Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas
Segment by Type
Syringes
Insulin Pens
Jet Injectors
Insulin Pumps
Segment by Application
Hospitals
Clinics
Homecare
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Insulin delivery devices that are currently available for the administration of insulin include syringes, insulin infusion pumps, jet injectors and pens.
The global Insulin Drug Delivery Devices market was valued at US$ 13980 million in 2023 and is anticipated to reach US$ 19310 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insulin Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Drug Delivery Devices.
Report Scope
The Insulin Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas
Segment by Type
Syringes
Insulin Pens
Jet Injectors
Insulin Pumps
Segment by Application
Hospitals
Clinics
Homecare
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Insulin Drug Delivery Devices Market Overview
1.1 Product Overview and Scope of Insulin Drug Delivery Devices
1.2 Insulin Drug Delivery Devices Segment by Type
1.2.1 Global Insulin Drug Delivery Devices Market Value Comparison by Type (2024-2030)
1.2.2 Syringes
1.2.3 Insulin Pens
1.2.4 Jet Injectors
1.2.5 Insulin Pumps
1.3 Insulin Drug Delivery Devices Segment by Application
1.3.1 Global Insulin Drug Delivery Devices Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare
1.3.5 Others
1.4 Global Insulin Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Insulin Drug Delivery Devices Revenue 2019-2030
1.4.2 Global Insulin Drug Delivery Devices Sales 2019-2030
1.4.3 Global Insulin Drug Delivery Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insulin Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Insulin Drug Delivery Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insulin Drug Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insulin Drug Delivery Devices Average Price by Manufacturers (2019-2024)
2.4 Global Insulin Drug Delivery Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Drug Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Drug Delivery Devices, Product Type & Application
2.7 Insulin Drug Delivery Devices Market Competitive Situation and Trends
2.7.1 Insulin Drug Delivery Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Drug Delivery Devices Players Market Share by Revenue
2.7.3 Global Insulin Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Drug Delivery Devices Retrospective Market Scenario by Region
3.1 Global Insulin Drug Delivery Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insulin Drug Delivery Devices Global Insulin Drug Delivery Devices Sales by Region: 2019-2030
3.2.1 Global Insulin Drug Delivery Devices Sales by Region: 2019-2024
3.2.2 Global Insulin Drug Delivery Devices Sales by Region: 2025-2030
3.3 Global Insulin Drug Delivery Devices Global Insulin Drug Delivery Devices Revenue by Region: 2019-2030
3.3.1 Global Insulin Drug Delivery Devices Revenue by Region: 2019-2024
3.3.2 Global Insulin Drug Delivery Devices Revenue by Region: 2025-2030
3.4 North America Insulin Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Insulin Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insulin Drug Delivery Devices Sales by Country (2019-2030)
3.4.3 North America Insulin Drug Delivery Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Insulin Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insulin Drug Delivery Devices Sales by Country (2019-2030)
3.5.3 Europe Insulin Drug Delivery Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Drug Delivery Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insulin Drug Delivery Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Insulin Drug Delivery Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Insulin Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insulin Drug Delivery Devices Sales by Country (2019-2030)
3.7.3 Latin America Insulin Drug Delivery Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insulin Drug Delivery Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insulin Drug Delivery Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insulin Drug Delivery Devices Sales by Type (2019-2030)
4.1.1 Global Insulin Drug Delivery Devices Sales by Type (2019-2024)
4.1.2 Global Insulin Drug Delivery Devices Sales by Type (2025-2030)
4.1.3 Global Insulin Drug Delivery Devices Sales Market Share by Type (2019-2030)
4.2 Global Insulin Drug Delivery Devices Revenue by Type (2019-2030)
4.2.1 Global Insulin Drug Delivery Devices Revenue by Type (2019-2024)
4.2.2 Global Insulin Drug Delivery Devices Revenue by Type (2025-2030)
4.2.3 Global Insulin Drug Delivery Devices Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Drug Delivery Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insulin Drug Delivery Devices Sales by Application (2019-2030)
5.1.1 Global Insulin Drug Delivery Devices Sales by Application (2019-2024)
5.1.2 Global Insulin Drug Delivery Devices Sales by Application (2025-2030)
5.1.3 Global Insulin Drug Delivery Devices Sales Market Share by Application (2019-2030)
5.2 Global Insulin Drug Delivery Devices Revenue by Application (2019-2030)
5.2.1 Global Insulin Drug Delivery Devices Revenue by Application (2019-2024)
5.2.2 Global Insulin Drug Delivery Devices Revenue by Application (2025-2030)
5.2.3 Global Insulin Drug Delivery Devices Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Drug Delivery Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Insulin Drug Delivery Devices Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Insulin Drug Delivery Devices Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BD Insulin Drug Delivery Devices Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly Insulin Drug Delivery Devices Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Corporation Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medtronic Insulin Drug Delivery Devices Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Beta Bionics
6.6.1 Beta Bionics Corporation Information
6.6.2 Beta Bionics Description and Business Overview
6.6.3 Beta Bionics Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Beta Bionics Insulin Drug Delivery Devices Product Portfolio
6.6.5 Beta Bionics Recent Developments/Updates
6.7 Dance Biopharm
6.6.1 Dance Biopharm Corporation Information
6.6.2 Dance Biopharm Description and Business Overview
6.6.3 Dance Biopharm Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dance Biopharm Insulin Drug Delivery Devices Product Portfolio
6.7.5 Dance Biopharm Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Roche Insulin Drug Delivery Devices Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Tandem Diabetes Care
6.9.1 Tandem Diabetes Care Corporation Information
6.9.2 Tandem Diabetes Care Description and Business Overview
6.9.3 Tandem Diabetes Care Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Tandem Diabetes Care Insulin Drug Delivery Devices Product Portfolio
6.9.5 Tandem Diabetes Care Recent Developments/Updates
6.10 Animas
6.10.1 Animas Corporation Information
6.10.2 Animas Description and Business Overview
6.10.3 Animas Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Animas Insulin Drug Delivery Devices Product Portfolio
6.10.5 Animas Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Drug Delivery Devices Industry Chain Analysis
7.2 Insulin Drug Delivery Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Drug Delivery Devices Production Mode & Process
7.4 Insulin Drug Delivery Devices Sales and Marketing
7.4.1 Insulin Drug Delivery Devices Sales Channels
7.4.2 Insulin Drug Delivery Devices Distributors
7.5 Insulin Drug Delivery Devices Customers
8 Insulin Drug Delivery Devices Market Dynamics
8.1 Insulin Drug Delivery Devices Industry Trends
8.2 Insulin Drug Delivery Devices Market Drivers
8.3 Insulin Drug Delivery Devices Market Challenges
8.4 Insulin Drug Delivery Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Insulin Drug Delivery Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Insulin Drug Delivery Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Insulin Drug Delivery Devices Market Competitive Situation by Manufacturers in 2023
Table 4. Global Insulin Drug Delivery Devices Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Insulin Drug Delivery Devices Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Insulin Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Insulin Drug Delivery Devices Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Insulin Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Insulin Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Insulin Drug Delivery Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin Drug Delivery Devices, Product Type & Application
Table 12. Global Key Manufacturers of Insulin Drug Delivery Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Drug Delivery Devices as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Drug Delivery Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Insulin Drug Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 18. Global Insulin Drug Delivery Devices Sales Market Share by Region (2019-2024)
Table 19. Global Insulin Drug Delivery Devices Sales by Region (2025-2030) & (K Units)
Table 20. Global Insulin Drug Delivery Devices Sales Market Share by Region (2025-2030)
Table 21. Global Insulin Drug Delivery Devices Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Insulin Drug Delivery Devices Revenue Market Share by Region (2019-2024)
Table 23. Global Insulin Drug Delivery Devices Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Insulin Drug Delivery Devices Revenue Market Share by Region (2025-2030)
Table 25. North America Insulin Drug Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Insulin Drug Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 27. North America Insulin Drug Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 28. North America Insulin Drug Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Insulin Drug Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Insulin Drug Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Insulin Drug Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 32. Europe Insulin Drug Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 33. Europe Insulin Drug Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Insulin Drug Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Insulin Drug Delivery Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Insulin Drug Delivery Devices Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Insulin Drug Delivery Devices Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Insulin Drug Delivery Devices Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Insulin Drug Delivery Devices Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Insulin Drug Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Insulin Drug Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Insulin Drug Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Insulin Drug Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Insulin Drug Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Insulin Drug Delivery Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Insulin Drug Delivery Devices Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Insulin Drug Delivery Devices Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Insulin Drug Delivery Devices Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Insulin Drug Delivery Devices Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Insulin Drug Delivery Devices Sales (K Units) by Type (2019-2024)
Table 51. Global Insulin Drug Delivery Devices Sales (K Units) by Type (2025-2030)
Table 52. Global Insulin Drug Delivery Devices Sales Market Share by Type (2019-2024)
Table 53. Global Insulin Drug Delivery Devices Sales Market Share by Type (2025-2030)
Table 54. Global Insulin Drug Delivery Devices Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Insulin Drug Delivery Devices Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Insulin Drug Delivery Devices Revenue Market Share by Type (2019-2024)
Table 57. Global Insulin Drug Delivery Devices Revenue Market Share by Type (2025-2030)
Table 58. Global Insulin Drug Delivery Devices Price (USD/Unit) by Type (2019-2024)
Table 59. Global Insulin Drug Delivery Devices Price (USD/Unit) by Type (2025-2030)
Table 60. Global Insulin Drug Delivery Devices Sales (K Units) by Application (2019-2024)
Table 61. Global Insulin Drug Delivery Devices Sales (K Units) by Application (2025-2030)
Table 62. Global Insulin Drug Delivery Devices Sales Market Share by Application (2019-2024)
Table 63. Global Insulin Drug Delivery Devices Sales Market Share by Application (2025-2030)
Table 64. Global Insulin Drug Delivery Devices Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Insulin Drug Delivery Devices Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Insulin Drug Delivery Devices Revenue Market Share by Application (2019-2024)
Table 67. Global Insulin Drug Delivery Devices Revenue Market Share by Application (2025-2030)
Table 68. Global Insulin Drug Delivery Devices Price (USD/Unit) by Application (2019-2024)
Table 69. Global Insulin Drug Delivery Devices Price (USD/Unit) by Application (2025-2030)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Novo Nordisk Insulin Drug Delivery Devices Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Insulin Drug Delivery Devices Product
Table 79. Sanofi Recent Developments/Updates
Table 80. BD Corporation Information
Table 81. BD Description and Business Overview
Table 82. BD Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. BD Insulin Drug Delivery Devices Product
Table 84. BD Recent Developments/Updates
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Eli Lilly Insulin Drug Delivery Devices Product
Table 89. Eli Lilly Recent Developments/Updates
Table 90. Medtronic Corporation Information
Table 91. Medtronic Description and Business Overview
Table 92. Medtronic Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Medtronic Insulin Drug Delivery Devices Product
Table 94. Medtronic Recent Developments/Updates
Table 95. Beta Bionics Corporation Information
Table 96. Beta Bionics Description and Business Overview
Table 97. Beta Bionics Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Beta Bionics Insulin Drug Delivery Devices Product
Table 99. Beta Bionics Recent Developments/Updates
Table 100. Dance Biopharm Corporation Information
Table 101. Dance Biopharm Description and Business Overview
Table 102. Dance Biopharm Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Dance Biopharm Insulin Drug Delivery Devices Product
Table 104. Dance Biopharm Recent Developments/Updates
Table 105. Roche Corporation Information
Table 106. Roche Description and Business Overview
Table 107. Roche Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Roche Insulin Drug Delivery Devices Product
Table 109. Roche Recent Developments/Updates
Table 110. Tandem Diabetes Care Corporation Information
Table 111. Tandem Diabetes Care Description and Business Overview
Table 112. Tandem Diabetes Care Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Tandem Diabetes Care Insulin Drug Delivery Devices Product
Table 114. Tandem Diabetes Care Recent Developments/Updates
Table 115. Animas Corporation Information
Table 116. Animas Description and Business Overview
Table 117. Animas Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Animas Insulin Drug Delivery Devices Product
Table 119. Animas Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Insulin Drug Delivery Devices Distributors List
Table 123. Insulin Drug Delivery Devices Customers List
Table 124. Insulin Drug Delivery Devices Market Trends
Table 125. Insulin Drug Delivery Devices Market Drivers
Table 126. Insulin Drug Delivery Devices Market Challenges
Table 127. Insulin Drug Delivery Devices Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insulin Drug Delivery Devices
Figure 2. Global Insulin Drug Delivery Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Insulin Drug Delivery Devices Market Share by Type in 2023 & 2030
Figure 4. Syringes Product Picture
Figure 5. Insulin Pens Product Picture
Figure 6. Jet Injectors Product Picture
Figure 7. Insulin Pumps Product Picture
Figure 8. Global Insulin Drug Delivery Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Insulin Drug Delivery Devices Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Homecare
Figure 13. Others
Figure 14. Global Insulin Drug Delivery Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Insulin Drug Delivery Devices Market Size (2019-2030) & (US$ Million)
Figure 16. Global Insulin Drug Delivery Devices Sales (2019-2030) & (K Units)
Figure 17. Global Insulin Drug Delivery Devices Average Price (USD/Unit) & (2019-2030)
Figure 18. Insulin Drug Delivery Devices Report Years Considered
Figure 19. Insulin Drug Delivery Devices Sales Share by Manufacturers in 2023
Figure 20. Global Insulin Drug Delivery Devices Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Insulin Drug Delivery Devices Players: Market Share by Revenue in 2023
Figure 22. Insulin Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Insulin Drug Delivery Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Insulin Drug Delivery Devices Sales Market Share by Country (2019-2030)
Figure 25. North America Insulin Drug Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Insulin Drug Delivery Devices Sales Market Share by Country (2019-2030)
Figure 29. Europe Insulin Drug Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 30. Germany Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Insulin Drug Delivery Devices Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Insulin Drug Delivery Devices Revenue Market Share by Region (2019-2030)
Figure 37. China Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Insulin Drug Delivery Devices Sales Market Share by Country (2019-2030)
Figure 48. Latin America Insulin Drug Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Insulin Drug Delivery Devices Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Insulin Drug Delivery Devices Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Insulin Drug Delivery Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Insulin Drug Delivery Devices by Type (2019-2030)
Figure 58. Global Revenue Market Share of Insulin Drug Delivery Devices by Type (2019-2030)
Figure 59. Global Insulin Drug Delivery Devices Price (USD/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Insulin Drug Delivery Devices by Application (2019-2030)
Figure 61. Global Revenue Market Share of Insulin Drug Delivery Devices by Application (2019-2030)
Figure 62. Global Insulin Drug Delivery Devices Price (USD/Unit) by Application (2019-2030)
Figure 63. Insulin Drug Delivery Devices Value Chain
Figure 64. Insulin Drug Delivery Devices Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
